Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

dacuronium

Known as: 17-Hydroxypancuronium, 2 beta,16 beta-dipiperidino-5 alpha-androstane-17 beta-diol 3 alpha-acetato dimethobromide, Piperidinium, 3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis-(1-methyl- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Three structurally complex flavaglines of the cyclopenta[bc]benzopyran type, named desacetylpyramidaglains A, C, D (1-3), and the… Expand
2007
2007
4-Hydroxyandrost-4-ene-3,17-dione is a second generation, irreversible aromatase inhibitor and commonly used as anti breast… Expand
2004
2004
Five new taxanes, 5alpha,9alpha,10beta,13alpha-tetraacetoxy-14beta-O-(beta-d-glucopyranosyl)taxa-4(20),11-diene (1), 1beta,2alpha… Expand
2001
2001
Formestane (Lentaron(R), 4-hydroxyandrostenedione) is a steroidal aromatase inhibitor used for treatment of advanced breast… Expand
2000
2000
To obtain more insight in the relationship between physicochemical properties of neuromuscular blocking agents (NMBAs) and their… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
1979
1979
Antagonism by neostigmine of neuromuscular blockade produced by pancuronium or its metabolites was studied in the cat anterior… Expand
1977
1977
The renal and hepatic elimination and biotransformation, as well as the relation between disposition and duration of action of… Expand
1973
1973
  • I. G. Marshall
  • The Journal of pharmacy and pharmacology
  • 1973
  • Corpus ID: 33790425
Three recently‐introduced short‐acting neuromuscular blocking drugs with non‐depolarizing mechanisms of action, stercuronium… Expand
1973
1973
Abstract The neuromuscular blocking activities of the 3 short-acting non-depolarizing agents, stercuronium, dacuronium and AH8165… Expand
1970
1970
This paper presents the results of preliminary experience with a new steroid muscle relaxant, dacuronium bromide * (2B, 16B… Expand